创美药业2024年净利5328万元 同比增加3.78%

格隆汇
28 Mar

格隆汇3月28日丨创美药业(02289.HK)公告,于2024年,集团的营业收入为人民币44.35亿元,较2023年增加0.72%。集团归属于母公司股东的净利润为人民币5328万元,较2023年增加3.78%。于2024年,集团基本及稀释每股收益为人民币0.4934元,而2023年则为人民币0.4754元。董事会建议就截至2024年12月31日止年度派发末期股息每股人民币0.45元(含税)。收入...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10